Supporting Monoclonal Antibodies (mAbs) Production Processes Through An Integrated Offering

Stevanato Group provides a comprehensive range of packaging and delivery solutions for monoclonal antibodies (mAbs), a critical component in biologics. Their offerings include specialized drug containment systems designed to maintain the stability and efficacy of mAbs throughout their shelf life. These systems include high-quality glass vials, syringes, and cartridges, with advanced surface treatments to reduce interactions and enhance performance.

The company focuses on delivering optimized packaging that protects mAbs from degradation, contamination, and other external factors, which is essential for ensuring the potency of these complex therapeutic proteins. Their packaging solutions incorporate innovative technologies, such as pre-sterilized systems, to meet the stringent demands of the biologics market.

In addition to primary packaging, Stevanato Group also provides integrated drug delivery systems like auto-injectors, and on-body delivery devices, which are designed to ensure ease of use, safety, and compliance. These devices help patients administer mAbs efficiently, further improving treatment outcomes.

Stevanato Group supports the entire lifecycle of mAb products, from R&D through production, with analytical and testing services to ensure product integrity. Their expertise in regulatory compliance also helps clients navigate the complex landscape of biologic approvals. With a focus on innovation, quality, and sustainability, Stevanato Group is a key partner in the biopharmaceutical industry, helping bring life-saving therapies to market.